| 000 | 01584 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516002503.0 | ||
| 264 | 0 | _c20101018 | |
| 008 | 201010s 0 0 ita d | ||
| 022 | _a0034-1193 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBragagni, Gianpaolo | |
| 245 | 0 | 0 |
_a[Echocardiographic evaluation of anti-tumor necrosis factor-alpha therapy with infliximab in patients without cardiac pathologies]. _h[electronic resource] |
| 260 |
_bRecenti progressi in medicina _c |
||
| 300 |
_a289-92 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aBehcet Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 |
_aDiastole _xphysiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 | _aEchocardiography, Doppler |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSystole _xphysiology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aLari, Federico | |
| 700 | 1 | _aMagenta, Gaetano | |
| 700 | 1 | _aBrogna, Raffaele | |
| 700 | 1 | _aZoli, Giorgio | |
| 773 | 0 |
_tRecenti progressi in medicina _gvol. 101 _gno. 7-8 _gp. 289-92 |
|
| 999 |
_c20173637 _d20173637 |
||